Trial
NCT04652518
LYT-100 in Post-acute COVID-19 Respiratory Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
PureTech
Collaborators
Clinipace Worldwide; Novotech (Australia) Pty Limited
Condition
Covid19
Intervention
LYT-100
Why stopped
Part A of the study was completed; Part B of the study was terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23